100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Test Bank - Introduction to Clinical Pharmacology, 9th Edition (Visovsky, 2019), Chapter 1-19 | All Chapters A+ LATEST R150,78
Add to cart

Exam (elaborations)

Test Bank - Introduction to Clinical Pharmacology, 9th Edition (Visovsky, 2019), Chapter 1-19 | All Chapters A+ LATEST

 15 views  0 purchase
  • Course
  • Institution
  • Book

Test Bank - Introduction to Clinical Pharmacology, 9th Edition (Visovsky, 2019), Chapter 1-19 | All Chapters A+ LATEST

Preview 4 out of 97  pages

  • October 2, 2023
  • 97
  • 2023/2024
  • Exam (elaborations)
  • Questions & answers
avatar-seller
lOMoARcPSD|30878495

, lOMoARcPSD|30878495




Test Bank - Pharmacology: A Patient-Centered Nursing Process Approach (9th Edition, 2017)
PHARMACOLOGY 9TH EDITION MCCUISTION TEST BANK



Table of Contents
Table of Chapter 28: Peptides, Antimalarial, and
Contents
Chapter 01: Drug Development Antifungals, and Antivirals
and Ethical Considerations
Chapter 02:
Pharmacokinetics,
Pharmacodynamics, and
Pharmacogenetics
Chapter 03: Cultural
Considerations Chapter 04:
Complementary and
Alternative Therapies
Chapter 05: Pediatric
Considerations Chapter 06:
Geriatric Considerations
Chapter 07: Drugs in Substance
Use Disorder
Chapter 08: The Nursing Process
and Patient-Centered Care
Chapter 09: Safety and
Quality Chapter 10: Drug
Administration Chapter 11:
Drug Calculations Chapter
12: Fluid Volume and
Electrolytes
Chapter 13: Vitamin and
Mineral Replacement
Chapter 14: Nutritional Support
Chapter 15: Adrenergic Agonists
and Antagonists
Chapter 16: Cholinergic Agonists
and Antagonists
Chapter 17: Stimulants
Chapter 18: Depressants
Chapter 19: Antiseizure
Drugs
Chapter 20: Drugs for Parkinsonism
and Alzheimer's Disease
Chapter 21: Drugs for
Neuromuscular Disorders and
Muscle Spasms Chapter 22:
Antipsychotics and Anxiolytics
Chapter 23: Antidepressants and
Mood Stabilizers
Chapter 24: Antiinflammatories
Chapter 25: Analgesics
Chapter 26: Antibacterials
Chapter 27: Antituberculars,

, lOMoARcPSD|30878495




Anthelmintic Thrombolytics Chapter 41:
Chapter 29: HIV- and Antihyperlipidemics and
AIDS-Related Drugs Peripheral Vasodilators
Chapter 30: Chapter 42: Gastrointestinal
Transplant Drugs Tract Disorders
Chapter 31: Chapter 43: Antiulcer Drugs
Vaccines Chapter Chapter 44: Eye and Ear
32: Anticancer Disorders Chapter 45:
Drugs Dermatologic Disorders
Chapter 33: Targeted Therapies to Chapter 46: Pituitary, Thyroid,
Treat Cancer Parathyroid, and Adrenal
Chapter 34: Biologic Disorders Chapter 47:
Response Modifiers Antidiabetics
Chapter 35: Upper Chapter 48: Urinary Disorders
Respiratory Chapter 49: Pregnancy and
Disorders Preterm Labor
Chapter 36: Lower Chapter 50: Labor, Delivery,
Respiratory and Postpartum
Disorders Chapter 51: Neonatal and
Chapter 37: Cardiac Newborn Chapter 52: Women's
Glycosides, Antianginals, Reproductive Health
and Antidysrhythmics Chapter 53: Men's Reproductive
Chapter 38: Diuretics Health Chapter 54: Sexually
Chapter 39: Antihypertensive Transmitted Infections
Chapter 40: Chapter 55: Adult and
Anticoagulants, Pediatric Emergency Drugs
Antiplatelets, and
Test Bank - Pharmacology: A Patient-Centered Nursing Process Approach (9th Edition, 2017)
PHARMACOLOGY 9TH EDITION MCCUISTION TEST BANK

, lOMoARcPSD|30878495




Test Bank - Pharmacology: A Patient-Centered Nursing Process Approach (9th Edition, 2017)
PHARMACOLOGY 9TH EDITION MCCUISTION TEST BANK




Chapter 01: Drug Development and Ethical Considerations
MULTIPLE CHOICE
1. The nurse is preparing to administer a schedule II injectable drug and is
drawing up half of the contents of a Single-use vial. Which nursing action is
correct?
a. Ask another nurse to observe and cosign wasting the remaining drug from the vial.
b. Keep the remaining amount in the patient’s drawer to give at the next dose.
c. Record the amount unused in the patient’s medication record.
d. Dispose of the vial with the remaining drug into a locked
collection box. ANS: A
Schedule II drugs are controlled substances, and all must be accounted for.
When wasting a portion of a drug, another nurse should observe and cosign that
a drug was wasted.
DIF: COGNITIVE LEVEL: Applying (Application)
TOP: NURSING PROCESS: Nursing Intervention
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies

2. A patient is prescribed a medication and asks the nurse if the drug is available
in a generic form. The nurse understands that a generic medication will have a
name that
a. is a registered trademark.
b. is always capitalized.
c. describes the drugs chemical structure.
d. is non-
proprietary. ANS:
D
The generic name is the official, non-proprietary name for a drug. The brand name
is the trademark name and is always capitalized. The chemical name describes the
chemical structure of the drug.
DIF: COGNITIVE LEVEL: Understanding
(Comprehension) TOP: NURSING PROCESS: N/A
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies

3. A patient receives a prescription on which the provider has noted that a
generic medication may be given.The patient asks the nurse what this means.
What will the nurse tell the patient about generic drugs?
a. They contain the same inert ingredients as brand-name drugs.
b. They have chemical structures that are identical to proprietary drugs.
c. They tend to be less expensive than brand-name drugs.
d. They undergo extensive testing before they are
marketed. ANS: C
Generic drugs are approved by the FDA if they are proved to be bioequivalent to
the brand- name drug. They tend to be less expensive because manufacturers of
these drugs do not have to do the extensive testing required of brand-name drugs
before marketing. They are not identical to brand-name drugs and often have
different inert ingredients.
DIF: COGNITIVE LEVEL: Applying (Application)
TOP: NURSING PROCESS: Nursing Intervention: Patient
Teaching MSC: NCLEX: Management of Client Care

4. The nurse reviews information about a drug and notes the initials USP after the
drugs official name. The nurse understands that this designation indicates the drug

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through EFT, credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying this summary from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller ASolution. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy this summary for R150,78. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

53340 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy summaries for 14 years now

Start selling
R150,78
  • (0)
Add to cart
Added